Figure 4.
Binding site of doxorubicin (white) with MERS-CoV PLpro surface representation (dark gray) (a). In (b), enlargement of the PLpro–doxorubicin interaction and PLpro residues are noted in gray and dashed yellow line indicate hydrogen bonds. Doxorubicin in white, small box on the left for 2D doxorubicin. Three hydrogen bonds formed between DOX and PLpro indicated with yellow dashed line.
